公司資料
Avenue Therapeutics 股價、新聞與催化劑
- 股票代碼:
- ATXI
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
0.36 USD (-10.00%)
收盤價
最後更新: 2026年10月1日
—
市值
股價為何變動
截至 2026年10月1日，ATXI 下跌 10.0%，收於 $0.3600。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
Avenue Therapeutics is a specialty pharmaceutical company focused on acute and hospital-based pain management. Its story revolves around trying to bring differentiated pain treatments into controlled clinical settings.
所在地與產業分類
Avenue Therapeutics is headquartered in the United States and listed on NASDAQ. It sits in specialty pharma and acute-care pain management.
商業模式特徵
The company depends on clinical and regulatory progress, commercial strategy, and the ability to sustain a narrow product focus. Investors track trial updates, development milestones, and capital runway.
生技產業定位
Avenue occupies a small acute-pain niche within specialty pharma. The stock tends to move on regulatory news and the market's view of the company’s ability to commercialize in a difficult category.
未來催化劑
- Avenue Therapeutics is largely a legacy and closeout story now, so the catalysts are any strategic or asset-resolution update rather than a live pipeline event. The market is mainly focused on residual value.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。